The impact of COVID-19 pandemic on patients with personality disorders

Malogiannis, Ioannis A.

doi:10.22365/jpsych.2023.004

Cited by 6 publications

(4 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additional interventions included (1) reinforcing strict masking and hygiene policies, (2) quarantine and isolation measures, (3) a visitor ban, and (4) allocation of staff to the care of residents with as little overlap with infected wards as possible. Although dementia decreases adherence with COVID-19 preventive measures, 5 all items were implemented with the appropriate caveat. Data were collected in a continuous line list.…”

Section: Methods and Resultsmentioning

confidence: 99%

Association of a coronavirus disease 2019 (COVID-19) vaccine booster with control of a COVID-19 outbreak in a long-term care facility in Switzerland, November to December 2021

Leiblein,

Winistörfer,

Seiler

et al. 2023

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

show abstract

Section: Methods and Resultsmentioning

confidence: 99%

Association of a coronavirus disease 2019 (COVID-19) vaccine booster with control of a COVID-19 outbreak in a long-term care facility in Switzerland, November to December 2021

Leiblein,

Winistörfer,

Seiler

et al. 2023

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

show abstract

“…Additionally, we observed a higher incidence of personality disorders compared to previous studies, of which could be influenced by the COVID-19 pandemic and its impact on mental health ( 22 ). Studies have reported worsened mental health symptoms and difficulties accessing healthcare during the pandemic, particularly for individuals with personality disorders ( 23 , 24 ). The CRHT intervention provided specialized care to patients during a time when access to hospitals was limited.…”

Section: Discussionmentioning

confidence: 99%

Patient satisfaction and outcomes of crisis resolution home treatment for the management of acute psychiatric crises: a study during the COVID-19 pandemic in Madrid

Moreno-Alonso,

Nieves-Carnicer,

Noguero-Alegre

et al. 2023

Front. Psychiatry

View full text Add to dashboard Cite

BackgroundCrisis Resolution Home Treatment (CRHT) seem to offer comparable results to the traditional hospitalization model, at a lower cost and offering greater flexibility and scope. However, in Madrid, its implementation in Mental Health did not occur until the midst of the COVID-19 pandemic. In this work we analysed the effectiveness of a mental health CRHT unit promoted during the COVID-19 pandemic, as well as the degree of satisfaction of patients and their families.Methods90 patients were treated by the CRHT unit in the period between October 2020 and June 2022. All patients met the inclusion criteria: (1) Acute psychopathological decompensation in patients suffering from psychotic disorders, major affective disorder, obsessive compulsive disorder, personality disorder and other severe mental disorders causing functional disability, according to ICD-10 diagnostic criteria; (2) Ages between 18–90 years old; (3) Living in the urban area of Vallecas, Madrid; and (4) Counting with sufficient social and family support. The effectiveness of the intervention was evaluated with the SF-36 health questionnaire, the caregiver burden with the Zarit questionnaire, and patient satisfaction with a survey specifically designed for this work.Results55 (61.1%) patients completed the SF-36 at baseline and at the end of hospitalization. Statistically significant improvements were observed in the 8 dimensions of the SF-36 (p < 0.05). However, CRHT did not achieve a statistically significant decrease in caregiver burden. Regarding the satisfaction of the patients with the attention and care received, an average score of 47.72/50 was obtained.ConclusionThe Crisis Resolution Home Treatment intervention resulted in significant improvement in patients’ quality of life with high satisfaction scores. However, it did not effectively reduce caregiver burden. Future research should focus on randomized controlled trials with long-term follow-up to assess the effectiveness of CRHT compared to traditional hospitalization and utilize specific assessment scales for different mental disorders.

show abstract

“…The final feature of BPD that is not observed in ADHD is paranoid ideation, which is described as a transient experience in which patients may undergo frantic efforts to avoid abandonment in response to real or imagined stress [38]. This is often an ongoing struggle for those living with BPD, as they have a heightened response to the behavior of others that can contribute to paranoia that they may have about a person or situation, putting further strain on their interpersonal relationships [39].…”

Section: What Are the Main Distinguishing Features Between Adhd And B...mentioning

confidence: 99%

Management Strategies for Borderline Personality Disorder and Bipolar Disorder Comorbidities in Adults with ADHD: A Narrative Review

MacDonald,

Sadek

2023

Brain Sciences

View full text Add to dashboard Cite

This narrative review examines two of the common comorbidities of attention-deficit/hyperactivity disorder, bipolar disorder (BD), and borderline personality disorder (BPD), which each share several common features with ADHD that can make assessment and diagnosis challenging. The review highlights some of the key symptomatic differences between adult ADHD and these disorders, allowing for more careful consideration before establishing a formal diagnosis. When the disorders are found to be comorbid, further complications may arise; thus, the review will also help to provide evidence-based treatment recommendations as well as suggestions on how to minimize adverse events. Incorporating evidence from systematic reviews, journal articles, randomized controlled trials, and case reports, this review highlights that the diagnosis of ADHD and some of its common comorbidities is challenging and requires full, in-depth assessment and management. The management strategies of these comorbidities will also be addressed, with emphasis on achieving mood stabilization for BD prior to initiating appropriate ADHD pharmacotherapy. Medications, specifically mood stabilizers, antipsychotics, and antidepressants, are fundamental in treating symptoms seen in BD and some cases of BPD, alongside psychotherapy and lifestyle modifications when appropriate. The review highlights the effectiveness of specific medications, including psychostimulants, atomoxetine, and bupropion, as add-on therapies to mood-stabilizing treatments for addressing ADHD symptoms in patients with these comorbidities. Despite limited research, the review will address various pharmacological and psychotherapeutic approaches for managing comorbid ADHD and BPD, emphasizing the need for further investigations to better understand the unique needs of this patient population.

show abstract

The impact of COVID-19 pandemic on patients with personality disorders

Cited by 6 publications

References 11 publications

Association of a coronavirus disease 2019 (COVID-19) vaccine booster with control of a COVID-19 outbreak in a long-term care facility in Switzerland, November to December 2021

Association of a coronavirus disease 2019 (COVID-19) vaccine booster with control of a COVID-19 outbreak in a long-term care facility in Switzerland, November to December 2021

Patient satisfaction and outcomes of crisis resolution home treatment for the management of acute psychiatric crises: a study during the COVID-19 pandemic in Madrid

Management Strategies for Borderline Personality Disorder and Bipolar Disorder Comorbidities in Adults with ADHD: A Narrative Review

Contact Info

Product

Resources

About